Transaction expected to close in the third or fourth quarter of calendar year 2025 DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the "Company" or "WBA") today announc ...

The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive.

Detailed price information for Walgreens Boots Alliance (WBA-Q) from The Globe and Mail including charting and trades.

Shares of Realty Income (NYSE:O) gained 1.76% over the past month, bringing its year-to-date gain to 8.67%. In addition to outperforming the S&P 500’s gain of 4.21% in 2025, O has provided ...

US Stock futures ticked higher early Thursday, with the S&P 500 now just shy of its all-time high, gaining 0.3% in pre-market trading. The Nasdaq 100 futures rose 0.4%, while Dow Jones futures added ...

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2025, which ended May 31, 2025.

Detailed price information for Walgreens Boots Alliance (WBA-Q) from The Globe and Mail including charting and trades.

It isn't a bad business model, but the U.S. market is largely saturated. Competition is fierce, and more and more ways to buy medication now exist, exacerbating the issue. They include grocery stores, ...